Table 2.
CSP |
LSA-1 |
AMA-1 |
MSP-1 |
MSP-3 |
||||||
Relative levela (95%CI) | P | Relative levela (95%CI) | P | Relative levela (95%CI) | P | Relative levela (95%CI) | P | Relative levela (95%CI) | P | |
Age (per 5 year increase) | 1.38 (1.04–1.84) | .02 | 1.86 (1.39–2.50) | <.001 | 3.60 (2.65–4.90) | <.001 | 1.43 (1.02–2.02) | .04 | 2.06 (1.57–2.70) | <.001 |
Living within 25m of swamp | 1.72 (1.19–2.50) | .004 | 1.86 (1.26–2.73) | .002 | 1.89 (1.27–2.83) | .002 | 1.68 (1.07–2.63) | .02 | 1.54 (1.08–2.19) | .02 |
Prior malaria incidence (per case/person year) | 1.20 (1.07–1.35) | .003 | 1.38 (1.22–1.56) | <.001 | 1.53 (1.34–1.73) | <.001 | 1.23 (1.07–1.42) | .004 | 1.11 (.99–1.24) | .07 |
NOTE. CI, confidence interval; associations with log-transformed antibody responses were estimated with multivariate linear regression.
Relative level indicates fold change in antibody level, e.g. a relative level of 2 indicates a doubling of antibody levels.